1. Effects of a human amniotic membrane extract on ARPE-19 cells.
- Author
-
Lulli M, Tartaro R, Papucci L, Magnelli L, Kaur IP, Caporossi T, Rizzo S, Mannini A, Giansanti F, and Schiavone N
- Subjects
- Humans, Cell Line, Epithelial-Mesenchymal Transition drug effects, Tissue Extracts pharmacology, Amnion cytology, Amnion drug effects, Retinal Pigment Epithelium drug effects, Retinal Pigment Epithelium metabolism, Retinal Pigment Epithelium cytology, Cell Survival drug effects, Apoptosis drug effects, Oxidative Stress drug effects, Cell Proliferation drug effects
- Abstract
Background: Human Amniotic Membrane (hAM) is endowed with several biological activities and might be considered an optimal tool in surgical treatment for different ophthalmic pathologies. We pioneered the surgical use of hAM to treat retinal pathologies such as macular holes, tears, and retinal detachments, and to overcome photoreceptor damage in age-related macular degeneration. Although hAM contributed to improved outcomes, the mechanisms of its effects are not yet fully understood. The characterization and explanation of the effects of hAM would allow the adoption of this new natural product in different retinal pathologies, operative contexts, and hAM formulations. At this end, we studied the properties of a hAM extract (hAME) on the ARPE-19 cells., Methods and Results: A non-denaturing sonication-based technique was developed to obtain a suitable hAME. Viability, proliferation, apoptosis, oxidative stress, and epithelial-mesenchymal transition (EMT) were studied in hAME-treated ARPE-19 cells. The hAME was able to increase ARPE-19 cell viability even in the presence of oxidative stress (H
2 O2 , TBHP). Moreover, hAME prevented the expression of EMT features, such as EMT-related proteins, fibrotic foci formation, and migration induced by different cytokines., Conclusions: Our results demonstrate that the hAME retains most of the properties observed in the whole tissue by others. The hAME, other than providing a manageable research tool, could represent a cost-effective and abundant drug to treat retinal pathologies in the future., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF